A biomarker for mild cognitive impairment
- PMID: 37402806
- DOI: 10.1038/s41582-023-00849-4
A biomarker for mild cognitive impairment
Comment on
-
NPTX2 in Cerebrospinal Fluid Predicts the Progression From Normal Cognition to Mild Cognitive Impairment.Ann Neurol. 2023 Oct;94(4):620-631. doi: 10.1002/ana.26725. Epub 2023 Jul 25. Ann Neurol. 2023. PMID: 37345460 Free PMC article.
References
Original article
-
- Soldan, A. et al. NPTX2 in cerebrospinal fluid predicts the progression from normal cognition to mild cognitive impairment. Ann. Neurol. https://doi.org/10.1002/ana.26725 (2023) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical